Maybe....BUT:
Data from the Phase 2 HIV-1 trial to be presented at key conferences, and also shared with potential partners, during late 2018/early 2019
• The successful results from this study are expected to facilitate commercialisation negotiations with these parties
Do you honestly believe the data will be presented to peers at these conferences, let alone shared with potential partners if it wasn't robust?
Ann: Presentation to Investors, page-9
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.94M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.1¢ | $4.293K | 204.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1189306 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 614877 | 2 |
View Market Depth
| Last trade - 14.33pm 31/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |